T-cell and NK-cell neoplasm
T-cell and NK-cell neoplasm
Explore linked clinical trials. Standard reference: MONDO:00246152 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Global Study of the PETAL Consortium | T-cell and NK-cell neoplasm | Recruiting | Not stated | 2026-04-09 | NCT06067347 | |
| Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms | Hemic and Lymphatic Diseases, T-cell and NK-cell neoplasm, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoproliferative syndrome | Recruiting | Phase 2 | 2026-01-29 | NCT04858256 |